{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:13:24Z","timestamp":1749701604311,"version":"3.41.0"},"reference-count":12,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA026770"],"award-info":[{"award-number":["R01DA026770"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA035684"],"award-info":[{"award-number":["K24DA035684"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Chronic hepatitis C infection has been linked to chronic kidney disease. Despite availability of all oral highly curative direct acting antiviral treatment for more than a decade, impact of HCV cure on extrinsically measured iohexol glomerular filtration rate (iGFR), a marker of kidney function, has not been rigorously evaluated. Over two recruitment periods (October 14, 2010 \u2013 July 23, 2012 and December 15, 2015 \u2013 September 12, 2019), we enrolled 208 participants with chronic HCV infection, 63% of whom were co-infected with HIV. We conducted linear mixed effects modeling to evaluate the change in iGFR slope among participants who were and were not cured from chronic HCV. Secondary outcomes included albuminuria (urine albumin-creatinine-ratio \u226530\u2009mg\/g). At baseline, the median age was 51 years (interquartile range: 47\u201356), most of whom were Black (85%), and male (71%). In the multivariable-adjusted model, including baseline iGFR and other covariates, the adjust difference in iGFR slope was 2.37\u2009mL\/min\/1.73 m<jats:sup>2<\/jats:sup> per year (95% CI: 0.72, 4.03, p\u2009=\u20090.0051) higher among HCV treated participants compared to untreated. HCV treatment status was not associated with probability of albuminuria. Among participants chronically infected with HCV, we identified a significant positive impact of HCV cure on kidney function over time. While iGFR declined overall, declines were attenuated among participants treated for HCV compared to participants who remained untreated.<\/jats:p>","DOI":"10.1371\/journal.pone.0325699","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:41:31Z","timestamp":1749663691000},"page":"e0325699","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal effect of HCV cure on markers of kidney disease"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-3172","authenticated-orcid":true,"given":"Javier","family":"Cepeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Zook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3013-4339","authenticated-orcid":true,"given":"Gregory","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"2","key":"pone.0325699.ref001","article-title":"Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus Infection","volume":"21","author":"C-H Liu","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"pone.0325699.ref002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268478","article-title":"Estimating the causal effect of treatment with direct-acting antivirals on kidney function among individuals with hepatitis C virus infection","volume":"17","author":"A O\u2019Donnell","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"pone.0325699.ref003","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.kint.2019.04.030","article-title":"Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease","volume":"97","author":"ME Sise","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"pone.0325699.ref004","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1681\/ASN.2010050479","article-title":"Estimated GFR associates with cardiovascular risk factors independently of measured GFR","volume":"22","author":"UD Mathisen","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"pone.0325699.ref005","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000002471","article-title":"Cross-sectional and longitudinal performance of creatinine-and cystatin C-based estimating equations relative to exogenously measured glomerular filtration rate in HIV-positive and HIV-negative persons","volume":"85","author":"GM Lucas","year":"2020","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"11","key":"pone.0325699.ref006","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1515\/CCLM.2010.318","article-title":"First certified reference material for cystatin C in human serum ERM-DA471\/IFCC","volume":"48","author":"A Grubb","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"19","key":"pone.0325699.ref007","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race","volume":"385","author":"LA Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0325699.ref008","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"PJ Johnson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"pone.0325699.ref009","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/QAD.0b013e3280d3587f","article-title":"Microalbuminuria in HIV infection","volume":"21","author":"LA Szczech","year":"2007","journal-title":"AIDS"},{"issue":"15","key":"pone.0325699.ref010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality","volume":"305","author":"CA Peralta","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"pone.0325699.ref011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1086\/320893","article-title":"Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management","volume":"33","author":"LA Szczech","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pone.0325699.ref012","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJM199302183280703","article-title":"Membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"328","author":"RJ Johnson","year":"1993","journal-title":"N Engl J Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:41:38Z","timestamp":1749663698000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325699"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325699","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}